The discovery and status of sibutramine as an anti-obesity drug

By Luque C.A.   Rey J.A.  

European Journal of Pharmacology, Vol. 440, Iss. 2, 2002-04 ,pp. : 119-128

Elsevier

Access to resources Recommend Favorite

Sibutramine: current status as an anti-obesity drug and its future perspectives

By Sharma Bikash   Henderson David C  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 12, 2008-08 ,pp. : 2161-2173

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of anti-obesity activity of duloxetine in comparison with sibutramine along with its anti-depressant activity: an experimental study in obese rats

By Chudasama H.P.   Bhatt P.A.  

Canadian Journal of Physiology and Pharmacology, Vol. 87, Iss. 11, 2009-11 ,pp. : 900-907

NRC Research Press

Access to resources Recommend Favorite

Anti-obesity drug development

By Bays Harold   Dujovne Carlos  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 9, 2002-09 ,pp. : 1189-1204

Informa Healthcare

Access to resources Recommend Favorite

Orlistat: its current status as an anti-obesity drug

By Ballinger A.   Peikin S.R.  

European Journal of Pharmacology, Vol. 440, Iss. 2, 2002-04 ,pp. : 109-117

Elsevier

Access to resources Recommend Favorite